CD274 and neoplasm: Interestingly, TP53 can exert anti-tumor immune activities by increasing antigen presentation, reducing PD-L1 expression [45, 46], and TP53 dysfunction could repress immunogenic activity by decrease the expression levels of almost all immune-related gene pathways [41].